These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7996390

  • 1. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
    Puigdemont A, Queralt M, Jansat JM, Martinez-Tobed A.
    J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of ebastine in children.
    Simons FE, Watson WT, Simons KJ.
    J Pediatr; 1993 Apr; 122(4):641-6. PubMed ID: 8096545
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y.
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, Nakashima M, Uematsu T.
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY, Argenti D, Wilson J, Garcia J, Heald D.
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ, Preston RA, Swan SK.
    Clin Pharmacokinet; 2007 May; 46(6):525-34. PubMed ID: 17518511
    [Abstract] [Full Text] [Related]

  • 7. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J, Liminana R, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150
    [Abstract] [Full Text] [Related]

  • 9. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
    Fujii T, Tanaka K, Matsumoto S, Hatoyama T, Nomura N, Tagawa M, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
    [Abstract] [Full Text] [Related]

  • 10. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R, García-Gea C, Puntes M, Pérez J, Esbrí R, Serra C, Fortea J, Barbanoj MJ.
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [Abstract] [Full Text] [Related]

  • 11. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, Rhodes G.
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [Abstract] [Full Text] [Related]

  • 12. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J, Schoemaker HC, Bruno R, Reinhoudt JF, Breimer DD, Cohen AF.
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [Abstract] [Full Text] [Related]

  • 13. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P, Gillen MS, Malik M, Pentikis H, Rhodes GR, Roberts DJ.
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [Abstract] [Full Text] [Related]

  • 14. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Antonijoan RM, García-Gea C, Puntes M, Valle M, Esbri R, Fortea J, Barbanoj MJ.
    Clin Drug Investig; 2007 Mar; 27(7):453-61. PubMed ID: 17563125
    [Abstract] [Full Text] [Related]

  • 15. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
    Frossard N, Benabdesselam O, Purohit A, Mounedji N, Pauli G.
    Fundam Clin Pharmacol; 2000 Mar; 14(4):409-13. PubMed ID: 11030449
    [Abstract] [Full Text] [Related]

  • 16. The effect of food on the bioavailability of ebastine.
    Pentikis HS, Huang MY, Dorr MB, Heald DL.
    Am J Ther; 1997 Mar; 4(2-3):80-4. PubMed ID: 10423596
    [Abstract] [Full Text] [Related]

  • 17. A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity.
    Barbanoj MJ, Antonijoan RM, García-Gea C, Morte A, Gich I, Gispert J, Garcia E, Esbrí R, Luria X.
    Int Arch Allergy Immunol; 2003 Nov; 132(3):263-7. PubMed ID: 14646388
    [Abstract] [Full Text] [Related]

  • 18. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
    Mattila MJ, Aranko K, Kuitunen T.
    Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
    Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ.
    Clin Pharmacokinet; 2004 Mar; 43(2):121-9. PubMed ID: 14748620
    [Abstract] [Full Text] [Related]

  • 20. Parametrization by nonlinear regression analysis of the active acid metabolite of ebastine using different weighting methods.
    Mariño EL, Jansat JM, March MA, Lastra CF.
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):546-9. PubMed ID: 8996850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.